PRCT Logo

PROCEPT BioRobotics Corporation (PRCT) 

NASDAQ
Market Cap
$5.31B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
677 of 776
Rank in Industry
88 of 100

Largest Insider Buys in Sector

PRCT Stock Price History Chart

PRCT Stock Performance

About PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United …

Insider Activity of PROCEPT BioRobotics Corporation

Over the last 12 months, insiders at PROCEPT BioRobotics Corporation have bought $0 and sold $73.6M worth of PROCEPT BioRobotics Corporation stock.

On average, over the past 5 years, insiders at PROCEPT BioRobotics Corporation have bought $39.47M and sold $27.71M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 940 shares for transaction amount of $22,961 was made by Wood Morgan Colby () on 2022‑03‑11.

List of Insider Buy and Sell Transactions, PROCEPT BioRobotics Corporation

2024-10-30SalePresident, CEO
288,461
0.5433%
$91.00$26.25M-0.80%
2024-10-15SaleEVP, CFO
25,000
0.044%
$72.47$1.81M+24.83%
2024-09-16SaleEVP, CFO
25,000
0.0484%
$82.51$2.06M-7.54%
2024-09-12Saledirector
44,867
0.0861%
$80.11$3.59M-5.21%
2024-09-11Saledirector
38,698
0.0751%
$77.54$3M+3.68%
2024-09-10Saledirector
36,500
0.0696%
$76.18$2.78M+1.20%
2024-09-05Saledirector
13,305
0.0256%
$76.37$1.02M+0.47%
2024-09-04Saledirector
36,212
0.0692%
$75.42$2.73M+0.84%
2024-09-04Saledirector
53,632
0.1025%
$75.42$4.04M+0.84%
2024-09-03Saledirector
35,120
0.0686%
$76.11$2.67M+2.05%
2024-09-03Saledirector
35,220
0.0688%
$76.12$2.68M+2.05%
2024-06-17SaleEVP, CLO, CORP. SEC.
10,000
0.018%
$62.18$621,764+18.46%
2024-06-10SaleEVP, Chief Comm. Officer
26,046
0.0503%
$68.24$1.78M+5.47%
2024-05-03SaleEVP, CLO, CORP. SEC.
30,432
0.058%
$62.97$1.92M+6.90%
2024-05-01Saledirector
20,000
0.0385%
$60.00$1.2M+13.45%
2024-03-18SalePresident, CEO
5,391
0.0106%
$48.83$263,243+34.65%
2024-03-18SaleEVP, CFO
1,024
0.002%
$48.83$50,002+34.65%
2024-03-18SaleEVP, CLO, CORP. SEC.
441
0.0009%
$48.83$21,534+34.65%
2024-03-18SaleEVP, Chief Comm. Officer
244
0.0005%
$48.83$11,915+34.65%
2024-03-06SalePresident, CEO
9,179
0.0179%
$46.67$428,384+36.63%

Insider Historical Profitability

<0.0001%
MOLL FREDERIC Hdirector
808233
1.4859%
$97.5511<0.0001%
Desai Antal Rohitdirector
197453
0.363%
$97.5518<0.0001%
Wood Morgan Colbydirector
112425
0.2067%
$97.5522+22.69%
Krummel Thomas Mdirector
45631
0.0839%
$97.5513<0.0001%
CPMG Inc10 percent owner
11222662
20.6319%
$97.5510<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Fidelity Investments$371.83M14.637.52M+2.2%+$8.01M0.03
Cpmg Inc$263.35M10.365.33M0%+$095.58
The Vanguard Group$209.87M8.264.25M+1.49%+$3.07M<0.01
BlackRock$162.72M6.43.29M-1.94%-$3.22M<0.01
T Rowe Price Investment Management Inc$145.29M5.722.94M-20.44%-$37.32M0.09
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.